10,077
Views
9
CrossRef citations to date
0
Altmetric
Review

Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches

ORCID Icon, &
Article: 2200540 | Received 13 Feb 2023, Accepted 04 Apr 2023, Published online: 18 Apr 2023